stella
beta
CTX-009 With Gemcitabine, Cisplatin, and Durvalumab as First-line Therapy in Patients With Unresectable or Metastatic Biliary Tract Cancers — Stella
Recruiting
Back to Metastatic Biliary Tract Cancer trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
Trial locations
(1 site)
United States
MD Anderson Cancer Center, Houston, Texas
View full record on ClinicalTrials.gov